These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 22492202)
1. Quantitative changes in endogenous DNA adducts correlate with conazole in vivo mutagenicity and tumorigenicity. Ross JA; Leavitt SA; Schmid JE; Nelson GB Mutagenesis; 2012 Sep; 27(5):541-9. PubMed ID: 22492202 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the mutations induced by conazole fungicides in vivo. Ross JA; Leavitt SA Mutagenesis; 2010 May; 25(3):231-4. PubMed ID: 20064898 [TBL] [Abstract][Full Text] [Related]
3. Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Allen JW; Wolf DC; George MH; Hester SD; Sun G; Thai SF; Delker DA; Moore T; Jones C; Nelson G; Roop BC; Leavitt S; Winkfield E; Ward WO; Nesnow S Toxicol Pathol; 2006; 34(7):853-62. PubMed ID: 17178687 [TBL] [Abstract][Full Text] [Related]
4. In vivo mutagenicity of conazole fungicides correlates with tumorigenicity. Ross JA; Moore T; Leavitt SA Mutagenesis; 2009 Mar; 24(2):149-52. PubMed ID: 19028983 [TBL] [Abstract][Full Text] [Related]
5. Toxicity profiles in rats treated with tumorigenic and nontumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Wolf DC; Allen JW; George MH; Hester SD; Sun G; Moore T; Thai SF; Delker D; Winkfield E; Leavitt S; Nelson G; Roop BC; Jones C; Thibodeaux J; Nesnow S Toxicol Pathol; 2006; 34(7):895-902. PubMed ID: 17178690 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiles in liver from rats treated with tumorigenic and non-tumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Hester SD; Wolf DC; Nesnow S; Thai SF Toxicol Pathol; 2006; 34(7):879-94. PubMed ID: 17178689 [TBL] [Abstract][Full Text] [Related]
7. A potential microRNA signature for tumorigenic conazoles in mouse liver. Ross JA; Blackman CF; Thai SF; Li Z; Kohan M; Jones CP; Chen T Mol Carcinog; 2010 Apr; 49(4):320-3. PubMed ID: 20175128 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional profiles in liver from mice treated with hepatotumorigenic and nonhepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil. Ward WO; Delker DA; Hester SD; Thai SF; Wolf DC; Allen JW; Nesnow S Toxicol Pathol; 2006; 34(7):863-78. PubMed ID: 17178688 [TBL] [Abstract][Full Text] [Related]
9. Three conazoles increase hepatic microsomal retinoic acid metabolism and decrease mouse hepatic retinoic acid levels in vivo. Chen PJ; Padgett WT; Moore T; Winnik W; Lambert GR; Thai SF; Hester SD; Nesnow S Toxicol Appl Pharmacol; 2009 Jan; 234(2):143-55. PubMed ID: 19010342 [TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicity. Shane BS; Zeiger E; Piegorsch WW; Booth ED; Goodman JI; Peffer RC Environ Mol Mutagen; 2012 Jan; 53(1):1-9. PubMed ID: 22329022 [TBL] [Abstract][Full Text] [Related]
11. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice. Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066 [TBL] [Abstract][Full Text] [Related]
12. Concordance of transcriptional and apical benchmark dose levels for conazole-induced liver effects in mice. Bhat VS; Hester SD; Nesnow S; Eastmond DA Toxicol Sci; 2013 Nov; 136(1):205-15. PubMed ID: 23970803 [TBL] [Abstract][Full Text] [Related]
13. 4-chloro-o-phenylenediamine induces a dose-related increase in G:C > T:A transversions and one major DNA adduct in the liver of Big Blue mice after 26 weeks in feed treatment. Staedtler F; Crespo-Perez J; Sagelsdorff P; Steiner S; Suter W Mutat Res; 1999 Nov; 430(1):121-30. PubMed ID: 10592323 [TBL] [Abstract][Full Text] [Related]
14. Two azole fungicides (carcinogenic triadimefon and non-carcinogenic myclobutanil) exhibit different hepatic cytochrome P450 activities in medaka fish. Lin CH; Chou PH; Chen PJ J Hazard Mater; 2014 Jul; 277():150-8. PubMed ID: 24962053 [TBL] [Abstract][Full Text] [Related]
15. Genotoxicity of 1,3-butadiene and its epoxy intermediates. Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF; Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413 [TBL] [Abstract][Full Text] [Related]
16. 4-Aminobiphenyl induces liver DNA adducts in both neonatal and adult mice but induces liver mutations only in neonatal mice. Chen T; Mittelstaedt RA; Beland FA; Heflich RH; Moore MM; Parsons BL Int J Cancer; 2005 Nov; 117(2):182-7. PubMed ID: 15880493 [TBL] [Abstract][Full Text] [Related]
17. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mei N; Arlt VM; Phillips DH; Heflich RH; Chen T Mutat Res; 2006 Dec; 602(1-2):83-91. PubMed ID: 17010389 [TBL] [Abstract][Full Text] [Related]
18. Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression. Nesnow S; Ward W; Moore T; Ren H; Hester SD Toxicol Sci; 2009 Jul; 110(1):68-83. PubMed ID: 19363144 [TBL] [Abstract][Full Text] [Related]
19. The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue transgenic F344 rats. Krebs O; Schäfer B; Wolff T; Oesterle D; Deml E; Sund M; Favor J Carcinogenesis; 1998 Feb; 19(2):241-5. PubMed ID: 9498271 [TBL] [Abstract][Full Text] [Related]
20. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L; Saranko CJ; Steen AM Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]